Intravenous Streptokinase in Acute Myocardial Infarction

• Status: Completed
• Trial end date: 1994-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine whether the administration of intravenous streptokinase (SK) early in the course of acute, transmural myocardial infarction would limit myocardial damage.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Washington
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Streptokinase

Criteria

Men and women, aged less than 75. Myocardial infarction onset within six hours.